Treatment of heel pain using arka pushpa kalka lepa and diclofenac sodium tablet orally

OPEN LABELLED RANDOMIZED COMPARATIVE CLINICAL TRIAL IN THE MANAGEMENT OF PAIN IN PLANTAR FASCITIS (VATAKANTAKA) WITH ARKA PUSHPA KALKA AND DICLOFENAC SODIUM

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2019/09/021324

Enrollment

Registered

2019-09-19

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M958- Other specified acquired deformities of musculoskeletal system

Interventions

Intervention1: Arka pushpa kalka: Route of administration - external application Dose - quantity required Frequency- Daily once in morning kept in situ for half an hour duration -7 days Control Int

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with clinical signs and symptoms of Plantar Facitis (Vatkantaka) 2.Age between 20 to 60 years. 3.Irrespective of religion, sex and socio-economic status

Exclusion criteria

Exclusion criteria: 1.Fractures of the foot , 2.Pagetâ??s disease affecting the calcanium, 3.Rupture of Achilles tendon, 4.vascular disorders of lower extrimities, 5.Systemic disorders likeTuberculosis, Diabetes mellitus, Leukaemia, HIV,

Design outcomes

Primary

Measure	Time frame
Reduce in the pain in the heelTimepoint: 7 days	—

Secondary

Measure	Time frame
complete absence of pain in the heel and improvement in the health and lifestyleTimepoint: 14 days	—

Countries

India

Contacts

Public ContactDrB S Savadi

S.J.G Ayurvedic Medical College & Hospital

savadi.savitha@gmail.com583231

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026